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Introduction:Introduction:

• Adverse drug events refer to an individual being
harmed due to taking a medication. These risks can
include side effects, damage to different organs, senses
impairment and more.
• The older adult population has the highest risk for
adverse drug events. Antibiotics and anticoagulants are
some examples of medication that cause higher
adverse events in the elderly. The risks can increase as
more medications are included.

Purpose:
These events are preventable with caution, but it is
important to recognize which medications are taken
and the possible interactions/risks for the elderly. The
purpose of this study was to evaluate the number of
high-risk medications used by older adults (age 60
and older) living In a low-income community-based
housing.

Methodology:
• Participants included had no history of dementia,
Alzheimer’s, or Lewy-body disease.
• Data was collected at senior apartment buildings
in the Richmond area and at the VCU Health
Clinic through the Richmond Health and Wellness
Program (RHWP) among Older Adults.
• Variables considered in the model include; 1)
Social Determinants of Health (SDH) as defined
by income, race/ethnicity, and education; 2)
Medication risk was measured by polypharmacy
definitions >=5 and >=7 medications.
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Results:
• Polypharmacy numbers >=5 and >=7 were
compared to identify the significance of the
definitions.
• Chi-square statistics shows a significance with a
p-value of 0.02.
\ • 79% were polypharmacy >=5 and 59% with >=7.
• Over half of the participants are considered in
the polypharmacy.
• Pie-charts indicate percentages of medical
conditions that each group consists of to help
further understand study implications.

Discussion:
• The results allow for us to see that even with a
smaller sample, the cut-off number for
polypharmacy can be essential.
• Further studies could include identifying and
comparing demographics for polypharmacy.
• Adverse drug events and drug-drug interaction
risks can also increase with these implications.

